Mary Audrey Ackerman
Hematology & Oncology · Columbia, SCNPI 1912988536
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in SC, where the typical reported total is $4,020.
Across 149 payments — averaging $13.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$237
- Amgen$187
- AstraZeneca$172
- Novartis$167
- E.r. Squibb & Sons, L.L.C.$161
- Genentech USA, Inc.$158
- plus $998 from 25 others
What the payments were for
- Food & beverage$2,080100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $237 |
| Amgen | 10 | $187 |
| AstraZeneca | 11 | $172 |
| Novartis | 9 | $167 |
| E.r. Squibb & Sons, L.L.C. | 19 | $161 |
| Genentech USA, Inc. | 17 | $158 |
| Merck | 9 | $141 |
| Incyte Corporation | 4 | $83 |
| Astellas Pharma US Inc | 5 | $81 |
| Johnson & Johnson | 5 | $65 |
| Bristol Myers Squibb | 3 | $58 |
| Puma Biotechnology, Inc. | 4 | $52 |
| Lilly USA, LLC | 3 | $48 |
| Clovis Oncology, Inc. | 3 | $47 |
| Gilead | 2 | $45 |
| Bayer | 3 | $38 |
| Eisai Inc. | 2 | $37 |
| Aurobindo Pharma USA, Inc. | 2 | $34 |
| Seagen Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Kyowa Kirin, Inc. | 2 | $24 |
| AbbVie | 1 | $24 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $23 |
| Taiho Oncology, Inc. | 1 | $22 |
| Pfizer | 2 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| Lexicon Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,080 in reported general payments places this provider in the 30th percentile of 166 hematology & oncology providers in South Carolina.
Other hematology & oncology in Columbia
- Fred KudrikColumbia$14K
- Anne HutchisonColumbia$13K
- Chaudry MushtaqColumbia$12K
- Robert SmithColumbia$12K
- Scott SommersColumbia$9K
- Suzanne FanningGreenville$927K
- Vikas DemblaSpartanburg$568K
- Stephen DyarGreenville$413K
- Kashyap PatelRock Hill$379K
- Tondre BuckSpartanburg$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.